-
1
Randomized Multicenter and Stratified Phase II Study of Gemcitabine Alone Versus Gemcitabine and Docetaxel in Patients with Metastatic or Relapsed Leiomyosarcomas: A Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)
Veröffentlicht in The oncologist (Dayton, Ohio)
VolltextArtikel -
2
Polyadenylic-polyuridylic acid plus locoregional radiotherapy versus chemotherapy with CMF in operable breast cancer : a 14 year follow-up analysis of a randomized trial of the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)
Veröffentlicht in Breast cancer research and treatment
VolltextArtikel -
3
-
4
-
5
-
6
-
7
-
8
-
9
ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists
Veröffentlicht in International journal of radiation oncology, biology, physics
VolltextArtikel -
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) study
Veröffentlicht in Journal of clinical oncology
VolltextArtikel